Technical Analysis for IMGO - Imago BioSciences, Inc

Grade Last Price % Change Price Change
F 18.08 1.57% 0.28
IMGO closed up 9.74 percent on Tuesday, December 7, 2021, on 3.15 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical IMGO trend table...

Date Alert Name Type % Chg
Jack-in-the-Box Bearish Bearish Swing Setup 1.57%
Volume Surge Other 1.57%
Calm After Storm Range Contraction 1.57%
Lower Bollinger Band Walk Weakness 1.57%
Inside Day Range Contraction 1.57%
Wide Bands Range Expansion 1.57%
Below Lower BB Weakness 1.57%
Oversold Stochastic Weakness 1.57%
Expansion Breakdown Bearish Swing Setup 11.47%
Volume Surge Other 11.47%
Older End-of-Day Signals for IMGO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
1.5x Volume Pace 22 minutes ago
Up 2% 22 minutes ago
Rose Above Previous Day's High 38 minutes ago
Up 1% 38 minutes ago
Rose Above Lower Bollinger Band about 1 hour ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Bone Marrow Blood Molecule Product Myelofibrosis Blood Disorders Hematopathology Myeloproliferative Neoplasm Polycythemia Essential Thrombocythemia Polycythemia Vera Primary Myelofibrosis Thrombocythemia

Is IMGO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 35.68
52 Week Low 14.61
Average Volume 106,807
200-Day Moving Average 0.00
50-Day Moving Average 23.47
20-Day Moving Average 22.18
10-Day Moving Average 21.45
Average True Range 2.67
ADX 15.77
+DI 10.99
-DI 27.65
Chandelier Exit (Long, 3 ATRs) 18.74
Chandelier Exit (Short, 3 ATRs) 22.61
Upper Bollinger Bands 26.13
Lower Bollinger Band 18.23
Percent B (%b) -0.05
BandWidth 35.64
MACD Line -1.33
MACD Signal Line -0.72
MACD Histogram -0.6048
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.64
Resistance 3 (R3) 20.37 19.15 20.16
Resistance 2 (R2) 19.15 18.43 19.29 20.00
Resistance 1 (R1) 18.48 17.99 18.82 18.75 19.85
Pivot Point 17.26 17.26 17.43 17.40 17.26
Support 1 (S1) 16.59 16.54 16.93 16.86 15.75
Support 2 (S2) 15.37 16.10 15.51 15.60
Support 3 (S3) 14.70 15.37 15.44
Support 4 (S4) 14.97